Paper32150868
Counteracting Radio-Resistance Using the Optimization of Radiotherapy.
Chevalier F. Int J Mol Sci, 2020. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Counteracting Radio-Resistance Using the Optimization of Radiotherapy. Papers, record 32150868. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32150868
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Radiation Tolerance | Major topic |
| Radiotherapy | Major topic |
| Humans |
Source PubMed
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31349558 | Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31349558 | PubMed |
| 2 | 31878191 | Hadrontherapy Interactions in Molecular and Cellular Biology. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31878191 | PubMed |
| 3 | 32023866 | TiO2 Nanomaterials Non-Controlled Contamination Could Be Hazardous for Normal Cells Located in the Field of Radiotherapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32023866 | PubMed |
| 4 | 31540114 | FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31540114 | PubMed |
| 5 | 31450688 | Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31450688 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41044220 | Effect of blueberry extract on enhancement of radiosensitivity in non-Hodgkin lymphoma by modulating proliferation and apoptosis. | Daru | 2025 | https://conductscience.org/library/papers/41044220 | PubMed |
| 40361506 | Particle Therapy to Overcome Cancer Radiation Resistance: "ARCHADE" Consortium Updates in Radiation Biology. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40361506 | PubMed |
| 39147708 | [Research Progress of Engineered Exosomes in the Treatment of Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2024 | https://conductscience.org/library/papers/39147708 | PubMed |
| 38920686 | Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors. | Cells | 2024 | https://conductscience.org/library/papers/38920686 | PubMed |
| 37155531 | Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37155531 | PubMed |
| 36922504 | Engineered exosomes from different sources for cancer-targeted therapy. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36922504 | PubMed |
| 36578381 | Radiotherapy prognosis-associated gene GCNT3 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. | Heliyon | 2022 | https://conductscience.org/library/papers/36578381 | PubMed |
| 36172186 | Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36172186 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FGFR3 | 2261 | PubTator's text mining | https://conductscience.org/library/genes/2261 | NCBI Gene |
| FGFR4 | 2264 | PubTator's text mining | https://conductscience.org/library/genes/2264 | NCBI Gene |
| GH1 | 2688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32150868
GET https://conductscience.org/api/papers/v1/32150868/authors